OTC Derivatives: The Story Continues

The saga involving the proposed regulation of over-the-counter derivatives, as covered in this post from last month, continues.

For several weeks, Senator Christopher Dodd (D., Conn.) has been expected to introduce a bill that addresses several of the stickier issues surrounding OTC derivatives. Over the past month, he has been working with Senator Bob Corker (R., Tenn.) to come up with a bipartisan plan. Other legislators who’ve been working on the bill are Jack Reed (D., Rhode Island) and Judd Gregg (R., New Hampshire).

The most contentious issue continues to revolve around “the end user exemptions,” says Luke Zubrod, director of U.S. public real estate advisory practice with Chatham Financial, a consulting firm specializing in managing interest rate and foreign exchange risk. That is, will businesses that use derivatives to hedge their risks be treated differently than financial institutions that participate in the market to a much greater extent? (more…)